This report was received from a consumer on 31-AUG-2015 via the (b) (6)  
(b) (6)
 and has not been medically confirmed. 
A 62-year-old adult male patient passed away on (b) (6)  (exact date unknown) while on H P Acthar 
(corticotropin) injection 80 U/ml, dose and frequency not reported, for the treatment of rheumatoid arthritis 
beginning on MAY2015. 
Follow-up information was received on 11SEP2015 from the patient's wife. The patient's wife reported the patient 
had not used Acthar since early (b) (6)  when he was hospitalized for gastrointestinal (GI) bleeding. She 
explained he couldn't seem to recover and was in and out of the hospital and rehab facility until he entered hospice 
care in AUG2015. The wife reported her husband passed away (b) (6)  and he was not using 
Acthar at the time of his death (discontinued early JUL2015).
Print Time: 13-JAN-2016 12:03 PM If a field is blank, there is no data for that field Page 36 of 38
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
The patient's medical history included type 1 diabetes, blood clots and Churg Strauss Syndrome which included GI 
bleeding. The patient suffered more than seven years of chronic illness and had used prednisone long term to treat 
Churg Strauss Syndrome. 
Death
Seriousness: Death
As Reported Causality:  Not Reported 
As Determined Causality: Unevaluable
Gastrointestinal haemorrhage
Seriousness: Hospitalization
As Reported Causality:  Not Reported
As Determined Causality: Unevaluable
Company comment - This case contains insufficient information to make a potential causal association with product
use. Causality- unevaluable.